Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies999
SynBio
SynBio is a biotechnology company focused on developing innovative medicines known as Biobetters for various diseases.
Sector
Subsector
Keywords
Location
InterMune
InterMune researches and develops therapies for pulmonology and orphan fibrotic diseases.
Sector
Subsector
Location
total rounds
Infinity Pharmaceuticals
Infinity Pharmaceuticals develops eganelisib, an oral immuno-oncology therapy targeting immune suppression in cancer.
Sector
Subsector
Location
total rounds
total raised
NeuroMax
NeuroMax is a Russian biotech company that develops and launches innovative products for treating nervous system diseases.
Sector
Subsector
Location
M&A Details1
Transaction name
Acquired by
Oncternal Therapeutics
announced date
Financials
Funding Rounds5
Number of Funding Rounds
Money Raised
Their latest funding was raised on 26.09.2017. Their latest investor Oracle. Their latest round Post-IPO Equity
Amzak Capital Management
Amzak Capital Management is a private investment firm that focuses on middle-market, fixed income, real estate and healthcare investments.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Boxer Capital
Boxer Capital supports biotech public companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
CAM Capital
CAM Capital is a VC firm focused on long-term growth.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
count Of Exists
Abingworth
Abingworth collaborates with entrepreneurs to develop impactful health products in life sciences.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Aisling Capital
Aisling Capital is a venture capital firm based in New York that focuses on investing in the pharmaceutical and biotechnology sectors.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Biotechnology Value Fund
Biotechnology Value Fund is a venture capital firm in California that focuses on undervalued investments in the biotechnology sector.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors9
Number of lead investors
Number of investors
Oracle
Oracle is a cloud services company that offers enterprise IT solutions.
Sector
Subsector
Location
total rounds
count Of Investments
count Of Exists
Joseph R. Hyde III
Mr. Hyde, in conjunction with Dr. Wills’ appointment as our Executive Chairman effective March 2, 2015, was appointed as the Board’s Lead Director and currently serves as a member of the Compensation Committee and the Nominating and Corporate Governance Committee. Previously, he served as Chairman of our Board of Directors from November 2000 through February 2015. Since 1989, Mr. Hyde has been the sole stockholder and President of Pittco Holdings, Inc., a private institutional investment company. Since 1996, when Mr. Hyde made a substantial contribution to support the research of one of the company’s founders, Mr. Hyde has been instrumental in helping direct and finance GTx and is our largest stockholder. Mr. Hyde was the Chairman of the Board of Directors of AutoZone, Inc. from 1986 to 1997 and the Chief Executive Officer of AutoZone from 1986 to 1996. From March 2005 to June 2007, Mr. Hyde served as the non-executive chairman of the Board of Directors of AutoZone, Inc., and continues to serve as a member of the Board. He was also Chairman and Chief Executive Officer of Malone & Hyde, Inc., AutoZone’s former parent company, from 1972 until 1988. Mr. Hyde also served as a director of FedEx Corporation from 1977 to 2011. As our largest stockholder and with a long history of serving as both Chairman and Chief Executive Officer of a large publicly-traded company and a member of the board of directors of other public companies, Mr. Hyde has continued to serve as a principal architect of our public company governance structure, and is an influential advisor to senior management on all matters of strategic importance.
count Of Investments
count Of Exists
MB Venture Partners
MB Venture Partners is a Tennessee-based venture capital firm that invests in life sciences companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders1
Andrew Romans
Andrew Romans is the founder of 7BC Venture Capital and Rubicon Venture Capital. Andrew lives by the motto - only invest if you can add value – otherwise, you do not deserve to be in the deal. He has financially outperformed more than 75% of all VCs in Silicon Valley. Before becoming a VC he was a VC-backed entrepreneur and 3x author, former tech VC and M&A investment banker, founder of The Founders Club & cofounder of Georgetown Angels. He is the author of Masters of Corporate Venture Capital, Masters of Blockchain & The Entrepreneurial Bible to Venture Capital, which have been translated into Chinese, Japanese, Italian and Russian by major publishers. Romans raised over $48m for tech startups he founded by the age of 28. He is fluent in English, French & German. MBA Georgetown University, which he completed on scholarship.
current job
organization founded
Andrew Romans
Employee Profiles41
Stephen Haynes
Associate director - information technology
Jason Shackelford
Vice president, finance and accounting
Mitchell S. Steiner
Chief Executive Officer and Vice Chairman of Board of Directors
Marc S. Hanover
President and Chief Operating Officer